1. Home
  2. PGEN vs NATH Comparison

PGEN vs NATH Comparison

Compare PGEN & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • NATH
  • Stock Information
  • Founded
  • PGEN 1998
  • NATH 1916
  • Country
  • PGEN United States
  • NATH United States
  • Employees
  • PGEN N/A
  • NATH N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • NATH Restaurants
  • Sector
  • PGEN Health Care
  • NATH Consumer Discretionary
  • Exchange
  • PGEN Nasdaq
  • NATH Nasdaq
  • Market Cap
  • PGEN 493.0M
  • NATH 442.2M
  • IPO Year
  • PGEN N/A
  • NATH N/A
  • Fundamental
  • Price
  • PGEN $3.89
  • NATH $108.92
  • Analyst Decision
  • PGEN Buy
  • NATH
  • Analyst Count
  • PGEN 5
  • NATH 0
  • Target Price
  • PGEN $7.50
  • NATH N/A
  • AVG Volume (30 Days)
  • PGEN 4.5M
  • NATH 44.7K
  • Earning Date
  • PGEN 11-13-2025
  • NATH 11-06-2025
  • Dividend Yield
  • PGEN N/A
  • NATH 1.84%
  • EPS Growth
  • PGEN N/A
  • NATH 9.62
  • EPS
  • PGEN N/A
  • NATH 5.77
  • Revenue
  • PGEN $4,340,000.00
  • NATH $150,413,000.00
  • Revenue This Year
  • PGEN $249.10
  • NATH N/A
  • Revenue Next Year
  • PGEN $710.03
  • NATH N/A
  • P/E Ratio
  • PGEN N/A
  • NATH $18.41
  • Revenue Growth
  • PGEN N/A
  • NATH 6.38
  • 52 Week Low
  • PGEN $0.65
  • NATH $75.15
  • 52 Week High
  • PGEN $5.23
  • NATH $118.50
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 49.47
  • NATH 51.86
  • Support Level
  • PGEN $3.86
  • NATH $105.66
  • Resistance Level
  • PGEN $4.35
  • NATH $110.44
  • Average True Range (ATR)
  • PGEN 0.27
  • NATH 2.49
  • MACD
  • PGEN -0.04
  • NATH -0.01
  • Stochastic Oscillator
  • PGEN 23.33
  • NATH 64.60

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: